American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Colgate-Palmolive
CL
|
+$242M |
| 2 |
Unilever
UL
|
+$231M |
| 3 |
Sysco
SYY
|
+$229M |
| 4 |
JPMorgan Chase
JPM
|
+$216M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$215M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$421M |
| 2 |
Illumina
ILMN
|
+$359M |
| 3 |
Boston Scientific
BSX
|
+$331M |
| 4 |
SBA Communications
SBAC
|
+$257M |
| 5 |
Waste Connections
WCN
|
+$248M |
Sector Composition
| 1 | Technology | 22.12% |
| 2 | Financials | 14.89% |
| 3 | Healthcare | 14.13% |
| 4 | Consumer Discretionary | 14.08% |
| 5 | Industrials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Halozyme
HALO
$8.99B
| $19M | 0.01% |
445,237
+12,150
| +3% | +$519K |
|
627
Fox Class A
FOXA
$26B
| $18.9M | 0.01% |
648,078
+473,578
| +271% | +$13.8M |
|
628
Southern Company
SO
$102B
| $18.9M | 0.01% |
307,214
-134,614
| -30% | -$8.27M |
|
629
Omega Healthcare
OHI
$12.5B
| $18.7M | 0.01% |
513,510
+3,820
| +0.7% | +$139K |
|
630
Amicus Therapeutics
FOLD
$2.46B
| $18.6M | 0.01% |
807,412
-905
| -0.1% | -$20.9K |
|
631
TD Synnex
SNX
$12.5B
| $18.6M | 0.01% |
228,587
-347,289
| -60% | -$28.3M |
|
632
Fidelity National Financial
FNF
$16.4B
| $18.6M | 0.01% |
495,076
+484,296
| +4,493% | +$18.2M |
|
633
Quanta Services
PWR
$57B
| $18.6M | 0.01% |
257,794
+131,991
| +105% | +$9.51M |
|
634
Teva Pharmaceuticals
TEVA
$22.9B
| $18.2M | 0.01% |
1,882,313
+32,560
| +2% | +$314K |
|
|
PMT
635
PennyMac Mortgage Investment
PMT
$1.07B
| $18.1M | 0.01% |
1,029,988
+75,763
| +8% | +$1.33M |
|
636
Invesco
IVZ
$10B
| $18.1M | 0.01% |
1,037,194
-563,922
| -35% | -$9.83M |
|
637
Kroger
KR
$45.2B
| $18M | 0.01% |
568,231
-501,893
| -47% | -$15.9M |
|
|
SAGE
638
DELISTED
Sage Therapeutics
SAGE
| $18M | 0.01% |
208,159
-11,845
| -5% | -$1.02M |
|
639
Alaska Air
ALK
$7.31B
| $18M | 0.01% |
346,186
+55,904
| +19% | +$2.91M |
|
640
BridgeBio Pharma
BBIO
$9.79B
| $18M | 0.01% |
252,865
+29,898
| +13% | +$2.13M |
|
641
East-West Bancorp
EWBC
$15.1B
| $18M | 0.01% |
354,351
+219,757
| +163% | +$11.1M |
|
642
American Woodmark
AMWD
$995M
| $17.5M | 0.01% |
+186,558
| New | +$17.5M |
|
643
Descartes Systems
DSGX
$8.96B
| $17.5M | 0.01% |
299,014
-40,200
| -12% | -$2.35M |
|
644
Iron Mountain
IRM
$28.6B
| $17.3M | 0.01% |
587,964
+422,757
| +256% | +$12.5M |
|
645
Unifirst Corp
UNF
$3.18B
| $17.3M | 0.01% |
81,879
-93,980
| -53% | -$19.9M |
|
|
DOC
646
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $17.3M | 0.01% |
972,086
-147,963
| -13% | -$2.63M |
|
647
HCA Healthcare
HCA
$94.8B
| $17.3M | 0.01% |
104,901
+99,744
| +1,934% | +$16.4M |
|
648
Seagate
STX
$41.7B
| $17.2M | 0.01% |
277,283
-46,372
| -14% | -$2.88M |
|
649
Onto Innovation
ONTO
$5.44B
| $17.2M | 0.01% |
+362,439
| New | +$17.2M |
|
|
EVBG
650
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $17.2M | 0.01% |
115,136
-37,939
| -25% | -$5.66M |
|